Daniel Clouatre's Contact Details

Daniel Clouatre's Company Details

Glykon Technologies Group LLC

Seattle, Washington, United States • 2 Employees
Health, Wellness & Fitness

WHO WE AREGlykon has been working with scientific leaders since 2003 to develop highly promising ingredients for the nutraceutical, the OTC and, ultimately, the pharmaceutical markets. We are developers of exciting and innovative products using cutting-edge ingredients combined with new delivery technologies of enormous potential in the categories of diabetes, Parkinson's Disease, triglycerides, dementia, Alzheimer's Disease, ketones, cortisol reduction, mitochondria health & mental enhancement, to name a few. THE FOUNDERS AND SCIENTIFIC ADVISORSMany of our founders were widely recognized by organizations such as Marquis Who's Who and the American College of Nutrition. You can find their resume in the documents below.Dr. James M. Dunn Dr. Dallas ClouatreDr. Brad DouglassDr. Kevin Matthew Connelly Dr. Harry G. Preuss Dr. Mark Saginor Daniel E. ClouatreGLYKON PATENTSGlykon currently owns 14 issued patents plus 2 additional patents that have been "allowed" but not yet assigned a patent number. These patents cover 2 of our most promising ingredients (KMgHCA & Bitter Melon Extract) plus one "New Chemical Entity" potential pharmaceutical, with an additional 13 pending patents covering delivery systems, as well as potential OTC applications and pharmaceuticals. OUR INGREDIENTS- Nutraceutical - Nutraceutical and Potential OTC (Dual Use)- New Chemical Entity (Potential Pharmaceuticals)HOW TO WORK TOGETHERWe are looking for partners that want to develop cutting-edge products in nutraceuticals/OTC/pharmaceuticals, with particular focus on categories like e-gaming, diabetes, triglycerides, and mental health. Our extensive and rapidly expanding patent portfolio will protect partners / buyers of the IP and serve as the foundation for successful development and marketing.